Considerable Overlap Seen for Children With Medical Complexity, Autism
By Elana Gotkine HealthDay Reporter
MONDAY, Feb. 3, 2025 -- There is considerable overlap between children with medical complexity (CMC) and autism, with significantly higher expenditures seen for those with medical complexity and autism, according to a study published online Feb. 3 in Pediatrics.
Philip H. Smith, Ph.D., from the A.J. Drexel Autism Institute at Drexel University in Philadelphia, and colleagues analyzed two national cross-sectional surveys: the National Survey of Children's Health (NSCH; 2017 to 2018, 2019 to 2022, and 2021 to 2022) and the Medical Expenditures Panel Survey (MEPS; combined 2010 to 2021) to estimate the overlapping prevalence of medical complexity and autism among U.S. children. Health care expenditures were compared for CMC and autism versus other children.
The researchers found that prevalence of CMC and autism in the most recent 2021 to 2022 NSCH was 59.28 percent using one algorithm and 17.56 percent using a more stringent algorithm. Using either algorithm, 41 percent of CMC had autism. CMC and autism had significantly greater median health care expenditures compared with other CMC and other children with autism based on the MEPS data.
"There is a critical need for research designed to understand the implications of this overlap for child service provision, caregiver supports, and long-term outcomes," the authors write.
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Declining Childhood Vaccination May Increase Risk for Vaccine-Preventable Infections
WEDNESDAY, April 30, 2025 -- Declining childhood vaccination rates may increase outbreaks of eliminated vaccine-preventable infections within the United States, leading to a...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...
AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors
TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.